IL94304A0 - Novel tumor-associated antigen,antibodies,compositions and uses therefor - Google Patents

Novel tumor-associated antigen,antibodies,compositions and uses therefor

Info

Publication number
IL94304A0
IL94304A0 IL94304A IL9430490A IL94304A0 IL 94304 A0 IL94304 A0 IL 94304A0 IL 94304 A IL94304 A IL 94304A IL 9430490 A IL9430490 A IL 9430490A IL 94304 A0 IL94304 A0 IL 94304A0
Authority
IL
Israel
Prior art keywords
antibodies
compositions
associated antigen
uses therefor
novel tumor
Prior art date
Application number
IL94304A
Other languages
English (en)
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Publication of IL94304A0 publication Critical patent/IL94304A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL94304A 1989-05-10 1990-05-06 Novel tumor-associated antigen,antibodies,compositions and uses therefor IL94304A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35065189A 1989-05-10 1989-05-10

Publications (1)

Publication Number Publication Date
IL94304A0 true IL94304A0 (en) 1991-03-10

Family

ID=23377628

Family Applications (1)

Application Number Title Priority Date Filing Date
IL94304A IL94304A0 (en) 1989-05-10 1990-05-06 Novel tumor-associated antigen,antibodies,compositions and uses therefor

Country Status (5)

Country Link
EP (1) EP0397419A3 (fr)
JP (1) JPH0347091A (fr)
AU (1) AU622548B2 (fr)
CA (1) CA2016385A1 (fr)
IL (1) IL94304A0 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4133791A1 (de) * 1991-10-11 1993-04-15 Behringwerke Ag Monoklonale antikoerper gegen tumorassoziierte antigene, verfahren zu ihrer herstellung und ihre verwendung
US6030797A (en) * 1992-10-08 2000-02-29 Dade Behring Marburg Gmbh Monoclonal antibodies against tumor-associated antigens, processes for the preparation thereof and the use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4471057A (en) * 1981-06-30 1984-09-11 The Wistar Institute Detection of colorectal carcinoma
DK172686A (da) * 1985-04-22 1986-10-23 Hybritech Inc Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet
ES8800604A1 (es) * 1985-04-22 1987-11-16 Hybritech Inc Un metodo para producir anticuerpos monoclonales

Also Published As

Publication number Publication date
EP0397419A2 (fr) 1990-11-14
AU622548B2 (en) 1992-04-09
EP0397419A3 (fr) 1991-04-03
AU5487890A (en) 1990-11-15
JPH0347091A (ja) 1991-02-28
CA2016385A1 (fr) 1990-11-10

Similar Documents

Publication Publication Date Title
NZ236000A (en) Oligomeric monoclonal igg antibody composition
GB8905669D0 (en) Modified antibodies
PL330111A1 (en) Concentyratyed antibody preparation
IL109445A0 (en) Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
IL90017A0 (en) Monoclonal antibodies
ZA898777B (en) Monoclonal antibodies
AU6031090A (en) Monoclonal antibodies against a tumor-associated antigen
EP0551308A4 (en) Novel peptide antigens and immunoassays, test kits and vaccines using the same
AU7165891A (en) Tumor-specific, cell surface-binding monoclonal antibodies
ZA89258B (en) Monoclonal antibodies
EP0485476A4 (en) Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
IL83342A0 (en) Monoclonal antibodies,their preparation and their use
AU622548B2 (en) Novel tumor-associated antigen, antibodies, compositions and uses therefor
IL95999A0 (en) Tumor-associated antigen
GB8927389D0 (en) Monoclonal antibodies
AU618720B2 (en) Monoclonal antibodies
GB9223676D0 (en) Modified antibodies
GB8820036D0 (en) Monoclonal antibodies
AU6964891A (en) Novel monoclonal antibody against human platelets
GB8816272D0 (en) Antibody & antigen
GB9318912D0 (en) Humanised antibodies
IE892311L (en) Improved monoclonal antibodies
AU4996193A (en) Pfemp3 malaria antigen, analogs, antibodies and uses thereof
IE892557L (en) Monoclonal antibodies
IE891298L (en) Monoclonal antibodies